Cancer Care Conference 2017: Delivering world class care
“For people who are worried they may have cancer, waiting for that all important test result is a nerve-wracking time. We have a duty to make sure this period of uncertainty is as short as possible.” – Jeremy Hunt, Secretary of State for Health
Half of all people born after 1960 will be diagnosed with cancer at some point in their life. The NHS’s Independent Cancer Taskforce estimates that an extra 30,000 patients could survive every year by 2020 through a combination of prevention, early diagnosis and improved treatment.
The taskforce, set up as part of the NHS Five Year Forward View, believes that this can be achieved through strong local leadership and by setting up “Cancer Alliances” to encourage co-operation across the health service.
This joined-up method would facilitate a more patient centred approach to cancer care which accounts for the mental as well as the physical implications of a cancer diagnosis. Technology also has a role to play through the innovative use of health data and the development of digital resources to allow patients to track their treatment and receive test results online.
Join us for the Cancer Care Conference 2017 where experts from across the health sector will discuss the changes needed to guarantee world class care by 2020.
Please register interest below and we will keep you updated
Topics covered on the day will include:
- To what extent are the Five Year Forward View and Sustainability and Transformation Plans driving a prevention based model of cancer care?
- How is Greater Manchester delivering the national cancer strategy at a local level?
- What improvements are needed before the NHS can meet its 28 day diagnosis target?
- What more can be done to support patients during and after cancer treatment?
- What are the latest advances in cancer research and how will these shape cancer care going forward?
- How are new developments helping to make personalised cancer care a reality?
- Which NHS trusts are leading the way on improving cancer care and what lessons can be learned from these examples?
- How can we use cancer data to improve diagnosis, treatment and the patient experience?
- How are improvements in radiotherapy improving outcomes?
- Network with delegates from across the NHS and discuss different approaches to meeting cancer targets by 2020.
- Gain unique insights from experts in field of cancer care.
- Analyse case studies and learn from the examples set by pioneering NHS trusts.
- Discuss how greater collaboration between health organisations can shift the focus towards the patient.
- See how new methods and techniques are transforming cancer care and driving improvements.
Registration and Coffee
Opening Remarks from Chair
Luciano Mutti, RCPI Medical Oncology, Chair In Cancer Research, University of Salford, Chairman of the Italian Group for Research and Therapy for Mesothelioma (GIMe)
The Greater Manchester cancer plan for Achieving world class cancer outcomes: Taking
charge in Greater Manchester
The plan sets out the ambitions for Greater Manchester Cancer, the cancer programme of the GMHSC Partnership. It is set out in eight domains reflecting a combination of the five key areas for change set out in Taking Charge and the six key workstreams of the national cancer strategy.
KEYNOTE - Dave Shackley, Medical Director, Greater Manchester Cancer (Invited)
Outcomes the Recovery Package delivers for people with cancer
The specific outcomes the RP aims to deliver are outlined in our Outcomes Framework and link to: Quality of life; Health outcomes; and Experience of care
Dany Bell, Specialist Advisor Treatment and Recovery, Macmillan Cancer Support
Dany qualified as a nurse in 1986 in Suffolk, initially working within the surgical specialty. In 1990 became ward sister on a ward caring for people having major surgery for upper GI, colorectal and urological cancers. Becoming interested in palliative care undertook the Diploma in Palliative Care at Homerton University, then in 1995 became a ward sister in a hospice in Wales. In 1997 was appointed team leader for a specialist palliative care team in a large teaching hospital in Bristol (North Bristol NHS Trust) working clinically as well as managing the service across a 2 site organisation. This was an unusually senior role for an acute Trust and sat alongside the Heads of Nursing within the Trust. In 2002 was successful in completing an MSc in Pain Management at University College of Medicine in Cardiff, with her dissertation being an exploration opiate use in renal impairment as the trust has a very busy renal unit that the palliative care team worked closely with for cancer and non-cancer diagnosis’.
In 2003 appointed as Lead Cancer Nurse in the Trust and in 2004 took on joint Cancer Manager and Lead Cancer Nurse role for the Trust. Dany continued to undertake this role until undertook a secondment as Head of Operations in May 2012 supporting the 4 hour emergency access target work and daily operational activity within the Trust. Alongside this still continued to oversee cancer programme as Cancer Manager supported by a full time Lead Cancer Nurse.
Refreshments & Networking Break
Working in partnership to achieve successful cancer outcomes
Overview of Macmillan Cancer Improvement Partnership (MCIP) in Manchester
Janet Tonge, MCIP Programme Director, Macmillan Cancer Improvement Partnership
The Macmillan Cancer Improvement Partnership was publically launched in June 2014 and is one of the largest Macmillan Cancer Support system redesign projects in England. It is a partnership between Macmillan, Manchester Health and Care Commissioning people affected by cancer, GPs, NHS hospital trusts, St Ann’s Hospice and Manchester City Council, with the aim of improving and increasing integration of cancer care across the city.
Punching Above Your Weight: a Highly Specialised service in a District General Hospital
Outlining how the NHS has enabled the UK to be a World leader in the surgical treatment of rare cancers
Faheez Mohamed, Consultant Surgeon, Hampshire Hospitals NHS Foundation Trust
After graduating from the University of Edinburgh in 1996, Faheez underwent surgical training in the North East of England with a period of research at the Washington Cancer Institute, USA under the supervision of Dr Paul Sugarbaker. He was appointed Consultant Surgeon at the Peritoneal Malignancy Institute, Basingstoke in 2009 with an interest in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of cancers that have spread to the peritoneal cavity. He is currently Clinical Director of the Department of General Surgery at Hampshire Hospitals Foundation Trust and is the Clinical Lead for the UK Colorectal Peritoneal Malignancy Clinical Database.
Lunch and Networking and Exhibition
Efforts to improve cancer outcomes in the England: promoting earlier diagnosis and using data to drive up standards of care
He will discuss national efforts to promote the earlier diagnosis of cancer and illustrate how the collection and use of national data on cancer care and outcomes can drive up standards of care.
KEYNOTE - Professor Mick Peake, Hon Consultant and Professor of Respiratory Medicine, University of Leicester; Clinical Lead for Early Diagnosis, National Cancer Registration and Analysis Service, Public Health England; Director, Centre for Cancer Outcomes, University College London Hospitals.
Prof. Peake has a long standing interest in the use of population-based data to drive improvements in the care and outcomes of cancer patients. He is the clinical lead for the ‘Be Clear on Cancer’ Public Awareness Campaigns. He has specialist expertise in thoracic cancers.
Professor Luciano Mutti, RCPI Medical Oncology, Chair In Cancer Research, University of Salford, Chairman of the Italian Group for Research and Therapy for Mesothelioma (GIMe) and Professor Marija Krstic- Demonacos, Chair in Molecular Medicine in the School of Environment & Life Sciences, University of Salford
Learning from every patient – using data to improve radiotherapy treatment
We will discuss methods of learning from patients previously treated with radiotherapy. These methodologies are designed to generate clinical hypothesis to improve future treatments.
Dr Alan McWilliam, Lecturer in Adaptive Radiotherapy, University of Manchester
Alan is the research team lead for adaptive radiotherapy, based in the Christie hospital. His main research interest is image based data mining where we aim to learn from previously treated patients to help inform the optimal way to treat future patients. He also works on the use of the MR linac, now installed and due to start treating patients in autumn 2018.
Cancer: where we are now and where we will be in the future
KEYNOTE - Professor Justin Stebbing MA FRCP FRCPath PhD, Professor of Cancer Medicine and Medical Oncology, Imperial College/ Imperial Healthcare NHS Trust (Invited)
Professor Stebbing is a Fellow of the Royal College of Physicians, the American Board of Internal Medicine and the Royal College of Pathologists, and sits on the advisory Boards of a number of international cancer committees. He chairs the World Vaccine Congress and is on the editorial board of a number of world leading general medical and cancer journals such as the Journal of Clinical Oncology. In 2011, Justin's team published in Nature Medicine, outlining the groundbreaking discovery of a new cancer-causing gene and a totally new theory in cancer drug resistance. He was recently appointed the government's first oncology professor funded by the National Institute for Health Research (NIHR) – the mechanism the government uses to fund research through the NHS.
|Date||Venue||Price from:||Status||Spaces||Book Now||Enquire|